Search clinical trials for: ISTO Technologies

Total 45165 results

French Innovative Leukemia Organisation

Completed

Study of Treatment High Risk and/or Low Risk Acute Lymphoblastic leukémia(ALL) Adults Stage III

Leukemia, Lymphocytic, Acute

France
University of Roma La Sapienza

Completed

Systematic Pelvic Lymphadenectomy Versus no Lymphadenectomy in Clinical Stage I-II Endometrial Cancer

Endometrial Cancer
Universidade Federal do Rio de Janeiro

Completed

Insulin Resistance in Women With Prolactinoma

Insulin Resistance | Hyperlipidemia | Prolactinoma

Brazil
Novacea

Unknown

AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme

Glioblastoma Multiforme

United States
French Innovative Leukemia Organisation

Completed

Lomustine and Intermediate Dose Cytarabine in Older Patients With AML

Acute Myeloid Leukemia

France
Skane University Hospital
Swedish Cancer Society; Europe Against Cancer (European Union Directorate General...

Completed

Randomized Controlled Trial of Human Papillomavirus Testing in Primary Cervical Cancer Screening (SWEDESCREEN)

Cervical Cancer | Cervical Intraepithelial Neoplasia

Sweden
Shandong University

Completed

Combination Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma Greater Than 3 cm (TACE-RFA)

Hepatocellular Carcinoma
University Hospital, Geneva

Unknown

Intravascular Ultrasound for Hepatocellular Carcinoma Staging

Hepatocellular Carcinoma

Switzerland
Celgene Corporation

Terminated

Study to Determine the Optimal Biologic Dose of CC-401 in Subjects With High-Risk Myeloid Leukemia

Myeloid Leukemia

United States
Pharmacyclics LLC.

Completed

Study of Motexafin Gadolinium for the Treatment of Non-Hodgkin's Lymphoma

Lymphoma | Non-Hodgkin's Lymphoma

United States
Novacea

Unknown

Study of AQ4N in Patients With Non Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, or Small Lymphocytic Leukemia

Non-Hodgkin's Lymphoma | Chronic Lymphocytic Leukemia | Small Lymphocytic Leukemia

United States
Pfizer

Completed

Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia

Hodgkin Disease | Thrombocytopenia | Non-Hodgkin Lymphoma

United States, Russian Federation, Singapore, Australia, France, Hong Kong, Greece, Poland
The Miriam Hospital
University of Pittsburgh; Brown University

Completed

Interactive Technologies to Increase Exercise Behavior

Cardiovascular Disease

United States
Hospices Civils de Lyon

Unknown

Remission Evaluation Before Intensified Treatment in Lymphoma: Impact of Positron Emission Tomography (PET) Using Fluorine-18-Floro-Deoxyglucose (FDG) in the Therapeutic Prescription. Medico-Economic Randomised Study (TEPELY)

Lymphoma

France
Hospices Civils de Lyon

Unknown

Treatment of Philadelphia-Positive Acute Lymphocytic Leukemia (Ph+ ALL) in the Elderly With Imatinib Mesylate (STI571) and Chemotherapy.

Acute Lymphocytic Leukemia

France
Hospices Civils de Lyon

Unknown

AFR10 - Combination Therapy of Imatinib Mesylate (IM) + Alpha-2A Interferon for Chronic Phase CML Patients Resistant or Refractory to IM Used as Single Therapy for at Least One Year

Chronic Myeloid Leukemia

France
Massachusetts General Hospital
Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center

Completed

Safety Study of Parathyroid Hormone in Patients Needing Additional Stem Cell Mobilization.

Lymphoma | Multiple Myeloma | Acute Myelogenous Leukemia

United States
University Health Network, Toronto

Completed

Study of Low Dose CT in Sarcoma Patients

Soft Tissue Sarcoma

Canada
University of Michigan Rogel Cancer Center

Terminated

Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the Blood

Myelodysplastic Syndromes | Leukemia | Multiple Myeloma | Lymphoma, Low-Grade | Lymphoma, Non-Hodgkin's

United States
University Hospital Tuebingen
Arbeitsgemeinschaft fur Internistische Onkologie; German Sarcoma Group

Completed

Bendamustin Hydrochloride in Patients With Soft Tissue Sarcoma (STS)

Sarcoma, Soft Tissue

Germany
University of Aarhus

Unknown

MRI in Staging Ovarian Cancer Using MRI Contrast Agent

Ovarian Cancer
University Hospital Tuebingen

Completed

Neoadjuvant Adriamycin and Ifosfamide Plus High-Dose ICE in Patients With Soft Tissue Sarcoma (STS)

Sarcoma, Soft Tissue

Germany
University of Glasgow
NHS Greater Glasgow and Clyde; Glasgow Western Infirmary

Unknown

A Pilot Study of the Treatment of Facial Nodular and Nodulocystic Basal Cell Carcinoma With Double Curettage and Cautery Followed by Application of Imiquimod to the Base

Basal Cell Carcinoma

United Kingdom
University Hospital, Geneva

Unknown

Biliary Tissue Sampling Using a Cytology Brush or the GIUM Catheter

Pancreatic Neoplasms | Cholangiocarcinoma | Pancreatitis

Argentina
University Hospital Tuebingen

Completed

Intradermal Vaccination With Stabilized Tumor mRNA - a Clinical Phase I/II Trial in Melanoma Patients

Malignant Melanoma

Germany
Cambridge Antibody Technology

Unknown

Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease

Leukemia | Hairy Cell Leukemia | HCL

United States, Poland, United Kingdom
Cambridge Antibody Technology

Unknown

Safety Study of CAT-8015 Immunotoxin in Patients With CLL, PLL or SLL With Advance Disease

Leukemia

United States, Poland
University Hospital Carl Gustav Carus

Unknown

Gemtuzumab Ozogamicin Before Allogeneic Stem Cell Transplantation

Acute Myeloid Leukemia | Allogeneic Transplantation

Germany
ViaCell

Completed

Infusion of Specially Treated Umbilical Cord Stem Cells After Chemoradiation Treatment for Blood Cancers

Acute Myeloid Leukemia | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Acute Lymphocytic Leukemia | Chronic Myelogenous Leukemia

United States
Rambam Health Care Campus

Unknown

Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma

Venous Thromboembolism | Non-Small Cell Lung Carcinoma

Israel
Eli Lilly and Company

Completed

Safety Confirmation Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma

Malignant Pleural Mesothelioma

Japan
Children's Hospital Medical Center, Cincinnati
The LAM Foundation; Tuberous Sclerosis Alliance

Completed

Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM

Tuberous Sclerosis | Lymphangioleiomyomatosis

United States
Children's Mercy Hospital Kansas City

Completed

Osteoporosis in Children With ALL

Leukemia, Lymphocytic, Acute, L1

United States
National Health Research Institutes, Taiwan
National Taiwan University Hospital; Mackay Memorial Hospital; China Medical... and other collaborators

Unknown

a Phase II Study in Primary Central Nervous System Lymphoma

Primary Central Nervous System Lymphoma

Taiwan
Latin American Cooperative Onco-Haematology Group...

Unknown

Study of Alemtuzumab to Treat Advanced Mycosis Fungoides/Sezary Syndrome

Mycosis Fungoides | Sezary Syndrome

Peru
PhytoCeutica

Completed

Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma

Hepatocellular Carcinoma | Liver Cancer

United States, Taiwan
Medtronic Cardiac Rhythm and Heart Failure
Medtronic; Medtronic BRC

Completed

VIBRANT Registry: Value of Information Based From Pacemaker Recordings and New Technologies

Bradycardia | Pacemaker

United States
Technische Universität Dresden

Unknown

Helicobacter - Lymphoma - Radiation Part I: Eradication, Part II: Radiation

Lymphoma | Lymphoma, Non-Hodgkin

Germany
Fundació Institut de Recerca de l'Hospital de la...

Completed

Secondary Prophylaxis After Variceal Bleeding in Non-Responders (KT-2000)

Cirrhosis | Portal Hypertension | Gastrointestinal Hemorrhage

Spain
National Taiwan University Hospital
National Science Council, Taiwan

Unknown

Effect of Polymorphisms in the IL-1 Gene Complex on the Development of Chronic Hepatitis and Hepatocellular Carcinoma

Hepatitis B | Carcinoma, Hepatocellular | Polymorphism, Genetic

Taiwan
pSiVida Limited
pSiOncology Private Limited

Unknown

Safety of 32P BioSilicon in Patients With Hepatocellular Carcinoma

Liver Cancer

Singapore
Eli Lilly and Company

Approved for marketing

ALIMTA (Pemetrexed) Alone or in Combination With Cisplatin for Patients With Malignant Mesothelioma.

Mesothelioma

United States, Brazil, Egypt, Saudi Arabia
LEO Pharma

Terminated

Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma

Liver Neoplasms

Spain, Canada, France, Italy, United Kingdom
Pharmacyclics LLC.

Completed

Study of Motexafin Gadolinium for the Treatment of Renal Cell (Kidney) Cancer

Kidney Neoplasms | Carcinoma, Renal Cell | Urologic Neoplasms | Urogenital Neoplasms

United States
Lab Discoveries Ltd.

Unknown

Blood Test for Ovarian Cancer Associated Antibodies (CAAb)

Ovarian Cancer

Israel
Wills Eye

Completed

Sub-Tenon Triamcinolone in the Prevention of Radiation-Induced Macular Edema

Melanoma

United States
Oncology Institute of Southern Switzerland

Completed

OnT4-Thyroglobulin Assay Before rhTSH-Aided Radioiodine Ablation

Differentiated Thyroid Carcinoma
McGill University
McGill University Health Centre/Research Institute of the McGill University...

Unknown

Study Combining Zevalin With High-Dose Chemotherapy Prior to Autologous StemCell Transplant in Patients With Relapsed, Refractory, or Transformed Non-Hodgkin's Lymphoma (Zevalin)

Non-Hodgkin's Lymphoma

Canada
National Center for Complementary and Integrative...

Completed

Women's Use of Alternative Medicine: A Multiethnic Study

Depression | Arthritis | Urinary Tract Infection | Osteoporosis | Heart Disease | Uterine Fibroids | High Blood Pressure | Headaches
LEO Pharma

Terminated

Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma

Liver Neoplasms

Canada, France, Italy, Spain, United Kingdom

Search clinical trials for: ISTO Technologies

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saint Lucia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations